Research Use Only (RUO). This article is for education and shares what published science says about a research compound. It is not medical advice, and nothing here is a suggestion to use any peptide on people or animals.
What is semaglutide? If you have seen the word online and felt lost, this guide gives you a plain answer. We will explain what semaglutide is, where it came from, and what published research has reported. We will keep the language simple and point every fact to a named source.
What is semaglutide?
Semaglutide is a peptide. A peptide is a short chain of amino acids, which are the small building blocks that make up proteins. Semaglutide is built to copy a natural gut hormone called GLP-1 (glucagon-like peptide-1).
Because it acts like GLP-1, scientists call semaglutide a GLP-1 receptor agonist. A receptor is a docking spot on a cell, and an agonist is a molecule that switches that spot on. According to the NIH StatPearls review, semaglutide shares about 94 percent of its structure with human GLP-1, which lets it bind to GLP-1 receptors found in the pancreas, the gut, and the brain.
Where does semaglutide come from?
Semaglutide was created by scientists at the drug company Novo Nordisk. Researchers studied the natural GLP-1 hormone, which breaks down in the body very fast. They changed parts of the molecule so it would last much longer and resist being broken down.
The result was a long-acting peptide that was first studied for blood sugar and later for body weight. Over the following years it was tested in large clinical trials, which are careful studies in people.
What does the research say about semaglutide?
Published clinical trials have measured how semaglutide affects blood sugar and body weight. These findings come from studies in people and are reported here as data, not as advice.
In a large trial called STEP 1, published in the New England Journal of Medicine in 2021 by Wilding and colleagues, adults with overweight or obesity who received once-weekly semaglutide had a mean body weight change of about negative 14.9 percent over 68 weeks, compared with about negative 2.4 percent in the placebo group. A placebo is a look-alike with no active peptide.
The NIH StatPearls review also explains the mechanism researchers study: semaglutide can increase glucose-dependent insulin release, slow how fast the stomach empties, and act on brain receptors linked to appetite. These are descriptions of what studies observed, not promises of any result.
Is semaglutide FDA approved?
Here is the plain regulatory picture. Semaglutide is approved by the U.S. Food and Drug Administration (FDA) as a prescription medicine under brand names such as Ozempic, Rybelsus, and Wegovy. In March 2024 the FDA also approved Wegovy to lower the risk of certain heart problems in specific adults, based on a trial of more than 17,600 people.
That approval applies to those finished, branded prescription products. The semaglutide material sold by Dissolv Labs is offered strictly as Research Use Only (RUO). It is not a medicine, it is not for human or animal use, and it is not intended for consumption. This guide is information, not medical advice.
How do researchers store and handle semaglutide?
In a laboratory setting, peptides like semaglutide are handled as sensitive research chemicals. Lab reference notes generally describe keeping the sealed material cold and away from light, and protecting it from heat and moisture, so the peptide stays stable for study.
Researchers also label containers clearly and keep records for their experiments. Nothing here is a direction to prepare or use the material in a living subject. Handling is limited to qualified laboratory work under the buyer's own safety rules.
Semaglutide vs other GLP-1 research peptides
Semaglutide is one of several peptides in the GLP-1 family that researchers study. Others, such as liraglutide and tirzepatide, are also studied in the scientific literature. They differ in structure and in how long they last in the body.
These peptides are often compared in reviews because they target related pathways. For any specific comparison, researchers rely on the published trial data for each individual peptide.
Semaglutide research materials at Dissolv Labs
Dissolv Labs offers the following as Research Use Only reference materials. They are not for human or animal use.
- Semaglutide (RUO reference material)
- Semaglutide 20mg (RUO reference material)
- Bacteriostatic Water 3ml (RUO laboratory reference material)
Frequently asked questions
Is semaglutide a peptide?
Yes. Semaglutide is a peptide, which is a short chain of amino acids. It is designed to act like the natural GLP-1 hormone.
What does semaglutide do in research studies?
Published trials have measured its effect on blood sugar and body weight. As reported in the NEJM STEP 1 trial, the semaglutide group had a larger mean weight change than the placebo group.
Is Dissolv Labs semaglutide the same as Ozempic or Wegovy?
No. Ozempic and Wegovy are FDA-approved prescription products. Dissolv Labs material is sold as Research Use Only and is not a medicine and not for human use.
Can I use semaglutide from Dissolv Labs?
No. It is Research Use Only. It is intended only for laboratory research by qualified people and is not for human or animal use or consumption.
The bottom line
Semaglutide is a long-acting GLP-1 receptor agonist peptide first developed by Novo Nordisk, and it is FDA-approved as a prescription drug under brand names like Ozempic and Wegovy. Published clinical trials, such as the NEJM STEP 1 study, reported effects on body weight versus placebo. The semaglutide sold by Dissolv Labs is Research Use Only and is not for human or animal use.
Sources
- Semaglutide, StatPearls, NIH National Library of Medicine
- Wilding et al., Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021 (STEP 1)
- U.S. FDA press announcement on Wegovy (semaglutide), March 2024
Disclaimer: All Dissolv Labs products are sold for Research Use Only and are not for human or veterinary use. This content is educational and is not medical advice, diagnosis, treatment guidance, or a recommendation to consume any substance.
